E-LIB Suche - Ergebnisse für: Eguale, T.

1

CO92 Comparative Effectiveness of Second-Line Immune Target..:

Mohamed, AF. ; Kandikatla, R. ; Yakkala, VK....
Value in Health. 27 (2024) 6 - p. S34 , 2024

Link: https://doi.org/10.1016/..

2

PCR218 Evaluating the Adherence of Reporting Patient Report..:

Mohamed, A.F. ; Kandikatla, R. ; Thirugnanam, A....
Value in Health. 26 (2023) 6 - p. S353 , 2023

Link: https://doi.org/10.1016/..

3

EE466 Correcting a Cost-Effectiveness Analysis (CEA) with S..:

Paredes, J.L. ; Rittenhouse, B. ; Eguale, T...
Value in Health. 26 (2023) 6 - p. S144 , 2023

Link: https://doi.org/10.1016/..

4

EPH146 Signal Detection Using Data from FDA Adverse Event R..:

Patel, U. ; Eguale, T. ; Rittenhouse, B....
Value in Health. 26 (2023) 6 - p. S191 , 2023

Link: https://doi.org/10.1016/..

5

PCR166 PRO Reporting and Methodological Rigor in NSCLC RCTs..:

Kandikatla, R. ; Fathima, A. ; Yakkala, V.K....
Value in Health. 26 (2023) 6 - p. S342-S343 , 2023

Link: https://doi.org/10.1016/..

6

EE321 A Re-Examination of a Cost-Minimization Analysis in M..:

Pretorius, C ; Rittenhouse, B ; Eguale, T.
Value in Health. 25 (2022) 7 - p. S397 , 2022

Link: https://doi.org/10.1016/..

7

EE84 A Reexamination of Drug Costs for Cetuximab and Panitu..:

Puskuru, S ; Rittenhouse, B ; Kallich, JD.
Value in Health. 25 (2022) 7 - p. S351 , 2022

Link: https://doi.org/10.1016/..

8

EPH9 Overall Mortality Among Patients with Hemophilia: A Sy..:

Sultan, I ; Syed, SS ; Fathima, A...
Value in Health. 25 (2022) 7 - p. S435 , 2022

Link: https://doi.org/10.1016/..

9

EPH52 Cause-Specific Mortality Among Patients with Hemophil..:

Sultan, I ; Syed, SS ; Fathima, A...
Value in Health. 25 (2022) 7 - p. S444 , 2022

Link: https://doi.org/10.1016/..

10

RWD111 Analysis on Prescribing Practices of Primary Care Pr..:

Syed, SS ; Eguale, T ; Mirica, M.
Value in Health. 25 (2022) 7 - p. S597 , 2022

Link: https://doi.org/10.1016/..

11

PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL..:

Gebrehiwet, P. ; Eguale, T. ; Segal, A..
Value in Health. 23 (2020) - p. S111-S112 , 2020

Link: https://doi.org/10.1016/..

12

PDB43 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES P..:

Gebrehiwet, P. ; Eguale, T. ; Segal, A..
Value in Health. 23 (2020) - p. S116 , 2020

Link: https://doi.org/10.1016/..

13

PSU11 SAFETY AND EFFICACY ANALYSIS OF ENOXAPARIN VERSUS RIV..:

Gebrehiwet, P. ; Rane, A. ; Pande, A...
Value in Health. 23 (2020) - p. S366-S367 , 2020

Link: https://doi.org/10.1016/..

14

PND47 COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATM..:

Yunusa, I. ; Rane, A. ; Sultan, I..
Value in Health. 23 (2020) - p. S267 , 2020

Link: https://doi.org/10.1016/..

15

PDB28 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES P..:

Gebrehiwet, P. ; Eguale, T. ; Segal, A..
Value in Health. 23 (2020) - p. S113 , 2020

Link: https://doi.org/10.1016/..